EVOLVING VALUE ASSESSMENT FOR CAR‑T CELL THERAPIES: COMPARATIVE REIMBURSEMENT PATHWAYS IN JAPAN, THE UNITED STATES, THE UNITED KINGDOM, FRANCE, AND GERMANY
EHA Library, Saaya Tsutsué,
4211025
PHASE 1 STUDY TO EVALUATE SUBCUTANEOUS BUDOPRUTUG, A LOW-FUCOSYLATED ANTI-CD19 MAB, IN HEALTHY VOLUNTEERS, AS A POTENTIAL TREATMENT FOR IMMUNE‑MEDIATED DISEASES WITH ADMINISTRATION OPTIONALITY
EHA Library, Stacey Luo,
4211054